It can be a challenge to navigate the amount of
information available about spinal cord injury - while
retaining what is relevant to your experience.
Register for The SCI Research Advocacy Course
today:
https://t.co/8fRumOcZJR
engagement-program-cep/
#SCI#healthED
CMSA evidence snapshot:
1. Validated
2. Reliable
3. Widely used in stroke rehab
NOCI supports teams in training + implementation. Book with us today. https://t.co/jKLAMATu0D
#CMSA#NeuroRehab
With #synapsebiomedical at #CRC2025 where we introduced the Diaphragmatic Pacing System (DPS) to Canada! A powerful shift in respiratory care for SCI, ALS & more—less invasive, more independence.
Proud to lead innovation in neuro rehab.
🔗 https://t.co/9y6SLw4YnB
#DPSCanada
🧠 Big updates from Neural Outcomes!
✅ CUE-T now available in partnership with @TJUHospital
✅ DPS featured on @7NewsAustralia
✅ CMSA training open—spots filling fast
✅ Explore clinical tools + eLearning options
📩 Read the full update: https://t.co/LmIUoEqd00
#NeuroRehab
Elevate your rehab practice with validated tools like the CUE-T. Available exclusively through NOCI in partnership with @TJUHospital.
✔️ Standardized
✔️ Clinically proven
✔️ Training + licensing included
Explore the collection: https://t.co/pp93UFwwXI #RehabTools#OT#PT
Increase your research knowledge.
Complete the #SCI Research Advocacy Course
and join the NASCIC for instant access to our
committees directly connected to clinicians and researchers
moving SCI Research forward today.
https://t.co/8fRumOcZJR
engagement-program-cep/
Tell your story, in your own words with advocacy
opportunities through the NASCIC.
As a graduate of the SCI Research Advocacy Course
you will have access to our project engagement
database. Register Today #spinalcordinjury
https://t.co/8fRumOcZJR
engagement-program-cep/
Congratulations to our valued partner @renetxbio for achieiving Fast Track Designation for their potential clinical therapy for chronic #sci, the AXER-204. This @US_FDA designation facilitates the review of drugs to treat serious conditions. https://t.co/09zUvK19gl
It's a big month for our partner @BrainQTech. Congratulations for achieving Breakthrough Designation from the @US_FDA for your revolutionary precision medicine therapy, that reduces the post #stroke disabilites.
https://t.co/Gkp9nTeob2
#NOCI is now the exclusive manufacturing and distributing e-comm supplier of the @TRI_UHN Hand Function Test. The TRI-HFT is an upper extremity assessment tool following #stroke or #spinalcordinjury, and is now available for clinical and insdustry use. https://t.co/jKLAMASWb5
It's almost that time!! NOCI CSO, Sukhvinder Kalsi-Ryan, will be co hosting the professorship visit of Dr. Allan Levi, @ the TRI Lyndhurst Centre May 30th. Dr. Levi will be sharing his knowledge of novel #treatment strategies for #spinalcord and peripheral nerve injury.
#fbf to @NeuroTrauma18 when Professor Armin Curt, Dr. Andrew Maas, Dr. Nicole von Steinbruches, and our CSO, Dr. Sukhvinder Kalsi-Ryan delivered an excellent update on outcomes in #TBI and #SCI. #proudsponsor
At the 44th Annual @ASIA_spine Meeting Presenting our product GRASSPtest Version 2. Great to see everyone there including Rüdiger Rupp, Norbert Weidner, @DPClinical and our vendor partner @VertexPharma,https://t.co/qvd4PQ5KEB
NOCI CEO/CSO Dr. Kalsi-Ryan, will be presenting NOCI product, @GRASSPtest Version 2, at the annual @ASIA_spine meeting May 1-4 in Rochester, Minnesota! https://t.co/pgn0i3pysT